Belpointe Asset Management’s Bausch Health BHC Stock Holding History

Belpointe Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-250	Closed	-$2.02K	–	875
2023 Q1	$2.02K	Hold	250	–	–	﹤0.01%	3301
2022 Q4	$1.57K	Buy	+250	New	+$1.75K	﹤0.01%	3336
2022 Q2	–	Sell	-5,373	Closed	-$123K	–	1145
2022 Q1	$123K	Buy	+5,373	New	+$131K	0.01%	1124

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Belpointe Asset Management's BHC Position: Q2 2023 in Review

Belpointe Asset Management sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 250 shares — an estimated $2.02K sold.

Belpointe Asset Management first reported a position in BHC in Q1 2022 and held it in 3 quarters. The position peaked at $123K in Q1 2022. 232 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

Belpointe Asset Management reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
Belpointe Asset Management sold 250 Bausch Health shares in Q2 2023, an estimated $2.02K.
Belpointe Asset Management first reported a position in Bausch Health in Q1 2022 and held it in 3 quarters.
Belpointe Asset Management's Bausch Health position peaked at $123K in Q1 2022.
232 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.